The impact of lifestyle modifications, diet, and vitamin supplementation on natural fertility by unknown
REVIEW Open Access
The impact of lifestyle modifications, diet, and
vitamin supplementation on natural fertility
Gretchen Garbe Collins* and Brooke V. Rossi
Abstract
Background: Infertility is a relatively common condition. When patients are confronted with this diagnosis, there
are medical, psychological, and financial sequelae. Patients often wonder if there is anything they can do to
optimize their natural fertility or increase the effectiveness of infertility treatments.
Findings: If there is a clear impact on fertility, such as with smoking and alcohol, cessation should be advised.
Similarly, weight loss should be recommended if the BMI is in the overweight and obese category, and weight gain
should be recommended for an underweight BMI. The evidence surrounding other lifestyle modifications is less
clear. There are conflicting data regarding an optimal fertility diet and consumption of vitamins and supplements.
Antioxidants seem to improve semen parameters in men, but the effect on female fertility is less clear. If conflicting
evidence exists, such as with caffeine consumption or exercise, moderation should be emphasized. Finally, the
diagnosis of infertility and subsequent fertility treatments are stressful for both partners. The psychological aspects
should not be ignored and methods such as yoga and cognitive behavioral therapy may be beneficial.
Conclusion: Continued research will determine the optimal lifestyle modifications to achieve pregnancy.
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Introduction
Infertility is defined as the inability of a couple to con-
ceive after 1 year of attempting pregnancy. According to
the CDC, in the United States, 10.9 % of women aged
15–44 have impaired fertility [1]. In non-mandated
states (states in the US that offer minimal or no insur-
ance coverage for fertility treatments), many patients
face expensive medical tests and treatments. Patients
and physicians are often curious if there are lifestyle
modifications to improve their fertility. This article will
focus on the evidence surrounding common lifestyle fac-
tors such as weight, exercise, substance use, diet, vitamin
and antioxidant supplementation, and stress and their
effects on fertility. A summary table of each lifestyle and
the associated relative risk is provided (Table 1).
Findings
Weight
Body mass index (BMI) and weight are closely related to
reproductive function. In a study investigating lifestyle
factors, time to conception increased in both overweight
(BMI >35 kg/m2) and underweight (BMI <19 kg/m2) indi-
viduals. After adjusting for age, menstrual status and other
lifestyle variables, compared to women with a normal
weight, women with a BMI <19 or ≥ 25–39 kg/m2 had a
relative risk of time to conception >12 months of 2.2 (95 %
CI 1.6-3.2) [2]. Given this, it is recommended that women
who are overweight or obese lose weight and women who
are underweight should gain weight to improve fertility.
Higher BMI is also associated with negative outcomes
for patients undergoing in vitro fertilization (IVF). In a
study of 233 IVF cycles, a BMI consistent with being
overweight (BMI 25–29.9 kg/m2) or obese (BMI ≥ 30 kg/m2)
was associated with a lower pregnancy rate (23 % and
22 %, respectively) compared with women of a BMI of
20–22.4 kg/m2 (pregnancy rate- 42 %) [3]. Similarly, a BMI
of ≥ 25 kg/m2 has a lower rate of blastocyst formation
compared to women with a BMI of <25 kg/m2 (54.9 versus
43.9 %, p < 0.007) [4].
Obesity does not seem to have the same impact on
male fertility. In a study of 483 men, BMI was unrelated
to sperm concentration, motility, or morphology. It was* Correspondence: gretchen.collins@uhhospitals.org
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only when the BMI was ≥ 35 kg/m2 that there was lower
total sperm count than normal weight men (a difference
of 86 million sperm) [5]. Similarly, a prospective study of
172 IVF cycles demonstrated no statistically significant
associations between men's BMI and pregnancy rate and
live birth rate among couples undergoing conventional
IVF [6]. However, in a study where couples required IVF
with ICSI, male obesity was related to lower odds of hav-
ing a live birth. Among the couples undergoing ICSI, the
odds of a live birth in couples with an obese male part-
ner were 84 % (95 % CI, 10 % to 97 %) lower than the
odds in couples with male partners of normal BMI [7].
Exercise
Exercise performed in different amounts and frequencies
has varying effects on male and female fertility. The
complex relationship between exercise and reproductive
potential is likely due to alterations in the hypothalamic-
pituitary axis. Extreme exercise may lead to anovulation
and infertility, whereas exercise may result in improved
ovulation and fertility in anovulatory obese patients. A
large Norwegian study found that women who were ac-
tive daily were 3.2 times more likely to have fertility
problems than inactive women (OR = 3.2, 95 % CI 1.3-
7.6). Additionally, in women who exercised a moderate
amount (either 16–30 min or 30–60 min), the risk of in-
fertility was decreased compared to women who exer-
cised < 15 min a day (OR = 0.3, 95 % CI 0.2-0.5; OR =
0.5, 95 % CI 0.3-0.9 respectively). Exercising to exhaus-
tion was associated with an increased risk of infertility
(OR = 2.3, 95 % CI 1.2-4.5) [8]. The Nurses’ Health
Study found that vigorous exercise for a minimum of
30 minutes a day was also associated with a decrease in
ovulatory disorder infertility [9].
The frequency and amount of exercise also seems to
impact outcomes in women pursuing IVF. A prospective
study examined the exercise regimens of 2,232 women
undergoing IVF. Women who reported regular exercise
had a similar live birth rate compared to women who
did not exercise (OR = 0.8, 95 % CI 0.7-1.0). Women
who exercised 4 or more hours per week for 1–9 years
were 40 % less likely to have a live birth (OR = 0.6, 95 %
CI: 0.4-0.8), three times more likely to experience cycle
cancellation (OR = 2.8, 95 % CI 1.5-5.3), twice as likely
to have an implantation failure (OR = 2.0, 95 % CI 1.4-
3.1) or pregnancy loss (OR = 2.0, 95 % CI 1.2-3.4) com-
pared to women who did not report exercise. In another
study of 2,572 women, there were no differences in
IVF outcomes between women who regularly exercised
and those who did not. However, compared to women
who did not exercise, women who exercised regularly
for 1–5 years were at greater risk for failure of cycle
stimulation (OR = 1.9, 95 % CI 1.2-3.2), implantation
failure (OR = 1.5, 95 % CI 1.1-2.0), and failure to de-
velop a live birth after a chemical pregnancy (OR = 1.9,
95 % CI 1.3-2.8) [10].
In contrast, regular exercise does not appear to affect
semen parameters. A prospective study of 2,261 men
found that none of the semen parameters were altered
with regular exercise, except bicycling >/= 5 hours a
week was associated with low sperm concentration (OR
= 1.92, 95 % CI 1.03-3.56) and low total motile sperm
(OR = 2.05, 95 % CI 1.19-3.56) [11].
Substance Use
When reviewing substance use studies it is important to
remember that substances may be used in congruence with
one another (ex: smoking and alcohol), and it may be
difficult to tease out the effect of each. Additionally, lifestyle
factors and consumption may fluctuate, and many studies
only capture a snapshot of a current lifestyle.
Tobacco
Approximately 30 % of reproductive age women and 35 %
of reproductive age men in the United States smoke ciga-
rettes [12]. The toxins in cigarette smoking have been cor-
related with subfertility, endocrine disorders, earlier onset
Table 1 List of lifestyle/consumption and their risk for infertility
Lifestyle Risk for Infertility
Weight (2)
BMI 25–39 or <19 RR- 2.2 (95 % CI 1.6-3.2)
Exercise (8)
<15 min/day OR- 0.5 (95 % CI 0.3-0.9)
16-30 or 30–60 min/day OR- 0.3 (95 % CI 0.2-0.5)
Exercise to exhaustion OR- 2.3 (95 % CI 1.2-4.5)
Tobacco (18)
Smokers versus Nonsmokers OR- 1.6 (95 % CI 1.34-1.91)
Alcohol (27)
High consumers RR- 1.59 (95 % CI 1.09-2.31)
Low consumers RR- 0.64 (95 % CI 0.46-0.90)
Diet and Nutrition (38)
Red Meats RR- 1.42 (95 % CI 0.98-2.06)
Chicken/Turkey RR- 1.53 (95 % CI 1.12-2.09)
Processed Meats RR- 1.04 (95 % CI 0.67-1.62)
Fish RR- 1.04 (95 % CI 0.64-1.70)
Low Fat Dairy (41)
2-4 servings/week RR- 1.32 (95 % CI 0.83-2.11)
5-6 servings/week RR- 1.77 (95 % CI 1.06-2.94)
High Fat Dairy
2-4 servings/week RR- 0.91 (95 % CI 0.67-1.24)
5-6 servings/week RR- 0.77 (95 % CI 0.52-1.15)
Caffeine (48)
(>5 cups coffee/day or >500 mg) OR- 1.45 (95 % CI 1.03-2.04)
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of menopause, premature ovarian failure, and decreased
implantation rate [13–17]. The early onset of menopause
associated with smoking suggests an association with early
follicular depletion. According to a meta-analysis, the odds
ratio for the risk of infertility in women smokers versus
non-smokers was 1.60 (95 % CI 1.34-1.91) [18]. It also
showed that smoking results in a delay of conception by
more than a year. Similarly, compared with non-smokers,
women smokers have decreased ovarian response to
hyperstimulation (12.12 +/−5 versus 8.62+/− 4 mature
oocytes retrieved), lower clinical pregnancy rate (29.6 vs.
10.0 %), and lower AMH levels (3.86+/−1.92 versus 3.06
+/−1.68 μg/l) [19]. Smoking is also associated with many
earlier pregnancy complications including spontaneous
miscarriages, bacterial vaginosis, preterm labor, and ec-
topic pregnancy [18, 20]. However, with smoking cessa-
tion, fecundity returns to a similar rate as to non-smokers,
even if cessation occurs within one year of attempting
conception [21]. For infertile women, simply discussing
and providing basic information on the effects of smok-
ing on infertility is highly effective in achieving smoking
cessation [22].
There is less consistency in the literature regarding the
effects of smoking on male infertility. One of the largest
studies evaluated 655 male smokers and 1,131 non-
smokers and found that cigarette smoking was associ-
ated with a significant decrease in sperm concentration
(millions of sperm/mL of semen) (67.7 ± 65.9 vs. 79.9 ±
75.0, p < 0.01) total sperm count (million) (229.4 ± 251.5
vs. 278.1 ± 264.2, p < 0.01), and total number of motile
sperm (million) (105.6 ± 132.7 vs. 126.6 ± 136.8, p < 0.01)
[23]. Similar to women, smoking cessation improves fe-
cundity and sperm parameters [24].
Alcohol
There are conflicting data regarding the effects of alco-
hol consumption on female infertility. Whereas some
studies quote an improvement in fecundity, others show
a detriment or no change. There are many studies that
suggest a trend toward increased alcohol consumption
and decreased conception [25, 26, 2]. In a large Swedish
study of 7,393 women, the risk of infertility was signifi-
cantly increased in women who were high consumers of
alcohol (>140 g alcohol, or 10 drinks, per week) (RR =
1.59, 95 % CI 1.09-2.31) and decreased in women who
were low consumers (less than 50 g, or 4 drinks, per
week) (RR = 0.64, 95 % CI 0.46–0.90) when compared
with women who were moderate consumers (between
50–140 g alcohol per week) [27]. Similarly, in a pro-
spective study of 430 Danish couples seeking first time
pregnancy, the odds of conception decreased with in-
creasing alcohol consumption in a dose–related fashion.
Compared with non-drinkers, women who consumed
1–5 drinks per week had a fecundity OR of 0.61
(95 % CI 0.04-0.93) and women consuming >10 drinks
per week an OR of 0.34 (95 % CI 0.22-0.52) [25]. In con-
trast, a population-based cohort study of 29,844 Danish
women suggested that time to conception was shorter in
women who drank wine compared to women that drank
no alcohol [28]. An Italian study of 1,769 women found no
connection between alcohol consumption and difficulty
conceiving [29]. Certainly alcohol consumption should be
avoided when pregnant, as no safe level of alcohol con-
sumption has been determined during pregnancy [30].
There does not appear to be an association between
alcohol consumption and abnormal semen analysis
parameters. Some studies demonstrated a detrimental
effect of alcohol on sperm parameters, while others
showed no or even a beneficial effect [31–33].
For women desiring IVF, two prospective cohort
studies evaluated alcohol consumption prior to the IVF
cycle and subsequent cycle outcome. In the first study,
an increase in one drink per day among women was
associated with 13 % fewer oocytes retrieved [34]. In the
women with any documented alcohol consumption,
there was a non-significant decreased odds of pregnancy.
In men, alcohol use was not associated with a change in
semen parameters. The strongest association between
men’s alcohol intake, pregnancy, and spontaneous abor-
tion was seen when the consumption occurred closest to
the time of semen sample collection. The second study
had differing findings. This study found that in women
who consumed at least four drinks/week there was a de-
creased live birth rate as compared to those who drank
less than four drinks a week (OR = 0.84, 95 % CI 0.71-
0.99) [35]. Couples in which both partners drank at least
4 drinks per week had a decreased likelihood of live
birth compared to couples in which both drank less than
4 drinks per week (OR = 0.79, 95 % CI 0.66-0.96).
Diet & Nutrition
The optimal fertility diet has yet to be established, and
the effects of nutritional factors on fertility are largely
unknown. However, dietary modifications have been
shown to improve ovulatory disorder infertility. Three
studies specifically evaluated the relationship between
protein intake and ovulatory disorder infertility. Two of
the studies were randomized trials that compared low
(15 % of energy) versus high protein (30 % of energy) di-
ets. The studies did not note any difference in ovulation
or circulating hormone levels of androgens between the
two groups [36, 37]. The third study was a large, pro-
spective study of 18,555 women. The consumption of
red meats and chicken/turkey was associated with a
greater rate of ovulatory disorder infertility (RR = 1.42,
95%CI 0.98-2.06; RR = 1.53, 95%CI 1.12-2.09), whereas
the consumption of processed meats and fish was not
associated with a greater rate of ovulatory disorder
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infertility (RR = 1.04, 95%CI 0.67-1.62; RR = 1.04, 95%CI
0.64-1.70, respectively). Consumption of foods rich in
vegetable protein showed a decreased risk of ovulatory
disorder infertility, but it did not reach statistical signifi-
cance [38].
In an effort to establish a fertility diet, the diets of a
cohort of 17,544 women were obtained and the repro-
ductive outcomes were followed. These data were ob-
tained from the Nurses’ Health Study II, a prospective
cohort study which started in 1989 and obtained infor-
mation through a questionnaire given to registered
nurses aged 25–42. Based on the dietary intake and re-
productive outcomes of these women, a high fertility
diet consists of:
– Low intake of trans-fat, with a simultaneous greater
intake of monounsaturated fat
– Low intake of animal protein with greater vegetable
protein intake
– High intake of high-fiber, low glycemic
carbohydrates
– Greater preference for high-fat dairy products
– High non-heme iron intake (mostly found in plant
foods)
The women who adhered to this type of diet had a
66 % (RR = 0.34, 95 % CI 0.23–0.48) lower risk of ovula-
tory disorder infertility and a 27 % (RR = 0.73, 95 % CI
0.57-0.95) lower risk of infertility due to other causes
[9]. In men, semen parameters may be improved by diets
consisting of limited processed meats and cheese, and by
increased low-fat dairy and fish [39].
Dairy products
The relationship between dairy consumption and ovula-
tory disorder infertility has also been studied. Dairy food
intake has been associated with a lower risk of insulin
resistance and ovulatory dysfunction [40]. However, data
from the Nurses’ Health Study II found contradictory re-
sults. An increase in low-fat dairy foods by 1 serving per
day (calorie count was held constant) was associated
with an 11 % greater risk of ovulatory disorder infertility
(95 % CI 2-21 %). For low-fat dairy foods, the relative
risk for ovulatory disorder infertility was 1.32 (95 % CI
0.83-2.11) for women consuming 2–4 servings per week
and 1.77 (95 % CI 1.06-2.94) for women consuming 5–6
servings per week. For high-fat dairy foods, the relative
risk was 0.91 (95 % CI 0.67-1.24) for women consuming
2–4 servings per week and 0.77 (95 % CI 0.52-1.15) for
women consuming 5–6 servings per week [41].
Soy and isoflavonoids
Soy may help female fertility, yet hinder male fertility.
There is a clear relationship between the consumption
of soy with low sperm concentration. Soy contains iso-
flavones that bind to the estrogen receptor and have
mild estrogenic activity [42, 43]. It is theorized that this
mild estrogenic activity may affect spermatogenesis, in-
duce capacitation and a premature acrosome reaction,
or lower testosterone levels; however, these findings are
from animal studies and the data are inconsistent [44].
Human data from a cross-sectional study of 99 men
demonstrated dietary intake of soy and isoflavones were
inversely related to sperm concentration. Consumption
of soy and isoflavones had more of an impact on semen
parameters of men with normal or above normal sperm
concentrations [45]. Other foods that contain phytoes-
trogens include walnuts, soybeans, cereals (oats, barley,
wheat, and rice), legumes, berries, apples, carrots, gin-
seng, fennel, and anise used to make bourbon and beer
[46].
In contrast to men, women may actually benefit from
consumption of phytoestrogens during infertility treat-
ments. A prospective cohort study evaluated live birth
rates at different amounts of soy isoflavone consumption
[47]. Compared to those with no soy isoflavone con-
sumption, the odds ratios of live births for women con-
suming 0.54-2.63 BMI/d was 1.32 (OR = 0.76-2.27, 95 %
CI 0.76-2.27), 1.87 (OR = 1.12-3.14, 95 % CI 1.12-3.14)
for women consuming 2.64-7.55 mg/d, and 1.77 (OR =
1.03-3.03, 95 % CI 1.03-3.03) for women consuming
7.56-27.89 mg/day. For reference, a 3 oz serving of tofu
has 20 mg isoflavones.
Caffeine
Daily caffeine consumption is very common among
reproductive-aged couples. The role that caffeine plays
in fertility is not well-defined. In a large multi-centered
European retrospective study, consumption of high
levels of caffeine (>5 cups of coffee/day or >500 mg) was
associated with an increased odds of subfertility (defined
as time to pregnancy 9.5 months or more) (OR = 1.45,
95 % CI 1.03-2.04) [48]. In contrast, a prospective Da-
nish study of 3,628 women evaluated the relationship
between time to pregnancy and caffeinated beverages,
and found no significant association between caffeine
consumption (coffee, tea, soda) and fecundity [49]. Simi-
larly, a cohort study of women without a history of infer-
tility followed them for 8 years to evaluate the effect of
caffeine on ovulatory disorder infertility [50]. Caffeine
intake did not increase the risk of ovulatory disorder in-
fertility, and there was no association between caffein-
ated coffee, decaffeinated coffee or tea and infertility.
There are also varying results among women undergo-
ing assisted reproductive technology (IVF). In a cohort
study of 619 women undergoing in-vitro fertilization
(IVF), caffeine intake did not reduce overall pregnancy
rates, however a reduction in the number of retrieved
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eggs was observed [51]. These findings are consistent with a
larger, prospective study that demonstrated that compared
with women who do not drink caffeine, the likelihood of live
birth was not significantly different for women who drank
low (0–800 mg/week; OR= 1.00, 95 % CI = 0.83–1.21), mod-
erate (>800–1400 mg/week; OR= 0.89, 95 % CI = 0.71–1.12),
or high levels of caffeine (>1400 mg/week; OR= 1.07,
95%CI = 0.85–1.34). Typically there are roughly 95 mg of
caffeine in an 8-ounce cup of coffee. Neither the type of
caffeinated drink (tea, soda, coffee) nor men’s caffeine in-
take had a significant effect on live birth rate. However,
increasing caffeine use had a significantly lower peak estra-
diol level, but no difference in number of oocytes re-
trieved, fertilization or implantation rate [52].
The American Society for Reproductive Medicine
states that moderate caffeine consumption (one to two
cups of coffee per day or its equivalent) before or during




Antioxidants act to reduce the amount of reactive oxygen
species, including hydroxyl radicals, superoxide anions,
and hydrogen peroxide [53]. When there is an imbalance
of reactive oxygen species there may be an increase in
sperm DNA structural damage, as well as an unclear link
to female infertility [54]. Commonly studied supplemen-
tal and dietary antioxidants include vitamin D, vitamin E,
vitamin C, β –carotene, and coenzyme Q10.
A study from of 1,192 infertile women found that
68.6 % of them were vitamin D insufficient (<32 ng/mL),
which is higher than the average population [55]. Ozkan
et al. performed a small prospective study that demon-
strated women with higher vitamin D levels (34.4 vs.
25.6 ng/mL) in their serum and follicular fluid had a
higher clinical pregnancy rate following IVF [56]. How-
ever, other studies did not confirm this result [57, 58].
Franasiak et al. performed a retrospective cohort study
of 517 women undergoing IVF, and found that preg-
nancy rates did not differ when comparing different
serum vitamin D levels (<20, 20–29.9, and ≥30 ng/mL)
[59]. Similarly, in a prospective pilot study of infertile
men, the incidence of low vitamin D was 76.9 % (mean
serum vitamin D level 23.6 ng/mL). After treatment with
vitamin D supplements, the rate of low sperm motility
(<40 %) improved [60]. Food sources high in vitamin D
levels include eggs, fatty fish, dairy, and cod liver oil.
Vitamin E also appears to be associated with positive
reproductive outcomes. Vitamin E supplementation
(20 mg) in women ≥35yo has been associated with a
shorter time to pregnancy (HR = 1.07, 95%CI 1.01-1.13)
[61]. Vitamin E supplementation in men may also help
to decrease oxidative damage to sperm and improve
motility. A study of 20 men randomized to vitamin E
and selenium or vitamin B-complex for 3 months re-
sulted in increased motility among subjects taking vita-
min E and selenium, but not with the vitamin B [62].
However, recommendations for vitamin E and selenium
supplementation should be done cautiously as high-
doses of these supplements have been associated with
increased incidence of prostate cancer, cardiac complica-
tions, and breast cancer in women. There is also an in-
crease in mortality at doses greater than 400 IU/day
[63]. Food sources high in vitamin E include sunflower
seeds, almonds, spinach, papaya, and dark leafy greens.
The role of vitamin C and β -carotene supplementation
on infertility is less clear and depends on the BMI. Ruder
et al. performed a secondary analysis of a randomized
controlled trial to determine whether antioxidant intake
decreased the time to pregnancy in women with un-
explained infertility [64]. While consumption of anti-
oxidants decreased time to pregnancy, it was dependent on
BMI and the antioxidant. A significantly shorter time to
pregnancy was seen in women with BMI < 25 kg/m2 with
increasing vitamin C (HR= 1.09, 95 % CI 1.03–1.15) and in
women with BMI ≥ 25 kg/m2 with increasing β -carotene
(HR = 1.29, 95 % CI 1.09–1.53). The optimal daily amount
of each antioxidant has not yet been suggested.
In men, varying amounts of vitamin C and β –caro-
tene supplementation may be associated with slight im-
provements in semen parameters. The Rochester Young
Men’s study was a cross-sectional study of male repro-
ductive health that assessed dietary intake and semen
quality in healthy men. Increased β-carotene (total daily
(supplement and diet): >6,059 μg/d vs. <2,520 μg) and
lutein (total daily: > 4,480 μg vs. <1,734) intake were as-
sociated with a 6.5 % higher progressively total motile
sperm count. Lycopene consumption (total daily:
>13,508 vs. <4,808 μg) was positively associated with a
1.7 % higher rate of morphologically normal sperm [54].
Vitamin C intake has varying results depending on the
dose and the study performed. Daily doses of 200 mg
and 1000 mg have been shown to lower sperm agglutin-
ation [64, 65], but in the Rochester Young Men’s study
there was a dose dependent improvement in semen
quality that corresponded to a total intake of about
148 mg/day [54]. More prospective studies clearly need
to be completed to determine the exact required doses
of the antioxidants and the effect on male semen ana-
lysis parameters.
Coenzyme Q10 is a component of the mitochondrial
respiratory chain that is required for energy metabolism.
CoQ10 is an antioxidant, an energy promoting agent, a
membrane stabilizer, and a regulator of mitochondrial
permeability transition pores. Given these actions, it is
theorized that this added cellular energy may improve
sperm count and motility in men and egg quality in
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women. In men, the amount of CoQ10 in the seminal
fluid shows a direct correlation with semen parameters.
A strong correlation between sperm count, motility and
ubiquinol (reduced from of CoQ10) has been reported
[66, 67]. Reduced levels of CoQ10 were noted in infertile
men with idiopathic and varicocele-associated asthenos-
permia [68]. Supplementation with CoQ10 (200 mg/day
twice daily) was studied in this population, and after
6 months of treatment there was an increase in seminal
plasma, sperm cells, and sperm cell motility [69]. In a
randomized trial between placebo and 300 mg coenzyme
Q10 supplementation, the men who were supplemented
with the CoQ10 had improved sperm count (57.8 vs.
47.8 million, p < 0.01), motility (27.6 vs. 23.1 %, p < 0.01),
and morphology (9.6 vs. 7.8 %, p < 0.07) [70]. The bene-
fits for CoQ10 supplementation in women are less clear.
Mouse models have shown improvement in fertility and
oocyte quality in old mice when treated with CoQ10
[71]; however, this model has yet to be repeated and no
human studies have been performed to support this
data. A study of women with diminished ovarian reserve
treated with dehydroepiandrosterone (DHEA) with or
without the addition of CoQ10 found no benefit in the
addition of CoQ10 [72]. There is likely minimal harm in
taking CoQ10 [73], but there is not strong evidence to
recommend taking it at this point to improve fertility.
Food sources with CoQ10 include seafood and meats,
but is difficult to obtain through the diet as there are
not many foods that contain CoQ10.
Folate
Folate is required for the synthesis of DNA, transfer
RNA, cysteine, and methionine, which are required
during periods of rapid cell growth. Given the peri-
conceptional period is a time of cellular growth, it was
postulated that folate supplementation may improve
reproductive outcomes. In a prospective cohort study of
232 women, live birth rates in women undergoing IVF
were 20 % higher (95 % CI 8-31 %) among women with
the highest amount of supplemental folate intake (>800
mcg/day) compared to women taking the lowest amount
(<400 mcg/day). This study also suggested that folate
supplementation was superior to dietary folate [74].
Similarly, a prospective cohort study of women undergo-
ing IVF in the Netherlands found that a doubling in the
follicular folate level was associated with three-fold in-
crease in pregnancy [75]. From this data, women should
be advised to take 800 mcg/day of folate during fertility
treatments and throughout pregnancy.
Dehydroepiandrosterone (DHEA)
Testosterone stimulates follicular development in the
presence of adequate gonadotropin concentrations. DHEA
may act as a pre-hormone of ovarian testosterone and
therefore may provide another treatment option. The role
of DHEA in fertility was also proposed when Gleicher et
al. studied women with diminished functional ovarian
reserve (defined as abnormally high Follicle Stimulating
Hormone levels and/or abnormally low anti-mullerian hor-
mone) [76]. They found that total testosterone levels were
lower in these women compared to similar age-matched
infertile women without diminished ovarian reserve. In
one study of 38 women over the age of 40 planning to start
IVF treatment, 25 mg DHEA was administered for
12 weeks prior to starting IVF medications. In this group
there were 10 spontaneous and 9 ongoing pregnancies
[77]. Unfortunately the same encouraging results were not
seen when women undergoing IVF were treated with
DHEA. A study of 31 infertile women who were treated
with DHEA supplementation (25 mg three times a day)
starting 2 months prior to an IVF cycle found no improve-
ment in total number of metaphase II oocytes (4.45 ± 0.47
vs. 2.09 ± 0.26), fertilization (3.65 ± 0.49 vs. 2.0 ± 0.27),
Grade I embryos (1.52 ± 0.25 vs. 0.55 ± 0.18), pregnancy
rate (30 % vs. 9.1 %) and live birth rate (25 % vs. 0 %)
compared to the 2 prior cycles without DHEA supplemen-
tation [78]. There is currently an ongoing randomized
controlled trial in England to evaluate the ovarian re-
sponse in women with poor ovarian reserve undergoing
IVF treated DHEA versus placebo [79]. There are min-
imal data about women with infertility taking DHEA
who are not undergoing IVF. Furthermore, there are no
proposed male benefits to DHEA supplementation.
Psychological Stress
Stress can have physical, mental, and emotional mani-
festations. Significant physical or psychological stress,
such as anorexia nervosa, alters reproductive function,
but the evidence regarding the effects of moderate
stress is mixed [80]. Louis et al. studied the effects of
stress on infertile couples by measuring salivary α-
amylase, which has been found to increase during
stressful stimuli. Alpha- amylase elevation corresponded
with a poorer probability of conception [81]. However,
a study of 2,695 women with infertility found no
difference in pregnancy outcomes depending on the
self-proclaimed stress level prior to treatments [82].
A meta-analysis including 14 studies on stress, did not
find a worse outcome in women with higher levels of
distress [83].
Physical, in-person, emotional support still seems to
be superior to support through the internet and chat
rooms, but the use of the internet for support can still
help people facing infertility by educating, empowering,
and diminishing feelings of depression [84]. Anxiety and
stress respond well to treatments such as cognitive be-
havioral therapy as well as mind-body interventions.
Yoga is one method of stress management and relaxation
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that may be beneficial for women undergoing fertility
treatments. Yoga helps with relaxation through meditation,
breathing, and achieving a deep sense of calmness. This
may help the woman communicate more clearly with phy-
sicians, maintain a healthier lifestyle, and be patient through
the sometimes long and cumbersome fertility treatments
[85]. Mind-body therapy that focuses on cognitive behavior
therapy, relaxation training, negative health behavior
modification, and social support components was found to
improve pregnancy rates for those undergoing their second
IVF treatment cycle (52 % vs. 20 % pregnancy rate, p < .05)
[86]. The stresses of infertility affect male partners as well,
and this stress may manifest as erectile dysfunction [87].
Offering men similar stress reducing treatment options
may also be effective in treating their stress.
Conclusions
It is the role of the physician to help the patient identify
modifiable risk factors, especially given the cost and time
commitment associated with infertility treatments. If pa-
tients are made aware of simple lifestyle changes that
could impact their fertility, they are generally receptive
to making those adjustments. All patients should be
encouraged to strive for a healthy, sustainable lifestyle.
In areas where there is clear evidence that a lifestyle be-
havior may impact fertility, such as smoking, the patient
should be encouraged to modify behavior. However,
many lifestyle changes are difficult to study, and when
the recommendations are less clear, the limitations of
evidence should be discussed. Exercising, as well as alco-
hol and caffeine consumption, should be performed in
moderation. More studies on the effects of stress on in-
fertility are also providing information about treatment
options such as cognitive behavioral therapy and yoga.
Making these lifestyle modifications may aid in achieving
the ultimate goal of a healthy pregnancy.
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